{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T02:19:51Z","timestamp":1794449991683,"version":"4.9.1"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Cancer Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Epigenetics &amp; Chromatin"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>5-hydroxymethylcytosine (5hmC), an epigenetic modification derived from the oxidation of 5-methylcytosine (5mC) by the ten-eleven translocation (TET) family of dioxygenases, plays a pivotal role in the regulation of gene expression, cellular differentiation, and developmental plasticity. Once considered an intermediate in DNA demethylation, 5hmC is now recognized as a stable and functionally significant epigenetic mark with distinct genomic distributions and significant regulatory implications. This review provides a comprehensive analysis of the biological functions of 5hmC in normal cellular processes, including its role in maintaining tissue-specific gene expression, lineage commitment, and genomic integrity. We also describe its role in cancer, the mechanistic underpinnings of its loss or redistribution in tumor cells, and how these changes contribute to oncogenic signaling pathways, epithelial-mesenchymal transition, and tumor heterogeneity. Furthermore, we explore the utility of 5hmC as a biomarker in cancer diagnostics and prognostics, supported by recent advances in sequencing technologies and cell-free DNA profiling. We also examine the intersection of 5hmC and chemotherapy, highlighting how aberrant 5hmC levels can influence drug resistance and sensitivity, and assess the therapeutic potential of targeting TET enzymes and associated pathways. By integrating insights from basic epigenetics, cancer biology, and therapeutic research, this review underscores the multifaceted role of 5hmC in human malignancies and outlines the translational opportunities for exploiting 5hmC-related mechanisms in precision oncology.<\/jats:p>","DOI":"10.1186\/s13072-025-00636-z","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T02:17:52Z","timestamp":1763345872000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["5-Hydroxymethylcytosine: a key epigenetic mark in cancer and chemotherapy response"],"prefix":"10.1186","volume":"18","author":[{"given":"Suhas S.","family":"Kharat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam K.","family":"Sharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"636_CR1","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/S1470-2045(20)30157-1","volume":"21","author":"GK Abou-Alfa","year":"2020","unstructured":"Abou-Alfa GK, Macarulla T, Javle MM, Kelley RK, Lubner SJ, Adeva J, et al. Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study. Lancet Oncol. 2020;21:796\u2013807.","journal-title":"Lancet Oncol"},{"key":"636_CR2","doi-asserted-by":"publisher","first-page":"8305","DOI":"10.18632\/oncotarget.14171","volume":"8","author":"JS Ahn","year":"2017","unstructured":"Ahn JS, Kim HJ, Kim YK, Lee SS, Ahn SY, Jung SH, et al. 5-Hydroxymethylcytosine correlates with epigenetic regulatory mutations, but may not have prognostic value in predicting survival in normal karyotype acute myeloid leukemia. Oncotarget. 2017;8:8305\u201314.","journal-title":"Oncotarget"},{"key":"636_CR3","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/17520363.2025.2483156","volume":"19","author":"N Aishan","year":"2025","unstructured":"Aishan N, Ju S, Zheng Z, Chen Y, Meng Q, He Q, et al. 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as potential diagnostic markers for breast cancer. Biomark Med. 2025;19:317\u201328.","journal-title":"Biomark Med"},{"key":"636_CR4","doi-asserted-by":"publisher","first-page":"5173","DOI":"10.1038\/s41467-022-32799-8","volume":"13","author":"M Arroyo","year":"2022","unstructured":"Arroyo M, Hastert FD, Zhadan A, Schelter F, Zimbelmann S, Rausch C, et al. Isoform-specific and ubiquitination dependent recruitment of Tet1 to replicating heterochromatin modulates methylcytosine oxidation. Nat Commun. 2022;13:5173.","journal-title":"Nat Commun"},{"key":"636_CR5","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.cell.2013.01.038","volume":"152","author":"SA Baker","year":"2013","unstructured":"Baker SA, Chen L, Wilkins AD, Yu P, Lichtarge O, Zoghbi HY. An AT-hook domain in MeCP2 determines the clinical course of Rett syndrome and related disorders. Cell. 2013;152:984\u201396.","journal-title":"Cell"},{"key":"636_CR6","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1158\/1541-7786.MCR-20-0359","volume":"18","author":"B Bao","year":"2020","unstructured":"Bao B, Teslow EA, Mitrea C, Boerner JL, Dyson G, Bollig-Fischer A. Role of TET1 and 5hmC in an obesity-linked pathway driving cancer stem cells in triple-negative breast cancer. Mol Cancer Res. 2020;18:1803\u201314.","journal-title":"Mol Cancer Res"},{"key":"636_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2020.100021","volume":"6","author":"Z Cai","year":"2021","unstructured":"Cai Z, Zhang J, He Y, Xia L, Dong X, Chen G, et al. Liquid biopsy by combining 5-hydroxymethylcytosine signatures of plasma cell-free DNA and protein biomarkers for diagnosis and prognosis of hepatocellular carcinoma. ESMO Open. 2021;6:100021.","journal-title":"ESMO Open"},{"key":"636_CR8","doi-asserted-by":"publisher","first-page":"4533","DOI":"10.1074\/jbc.M116.754580","volume":"292","author":"R Chen","year":"2017","unstructured":"Chen R, Zhang Q, Duan X, York P, Chen GD, Yin P, et al. The 5-Hydroxymethylcytosine (5hmC) Reader UHRF2 is required for normal levels of 5hmC in mouse adult brain and spatial learning and memory. J Biol Chem. 2017;292:4533\u201343.","journal-title":"J Biol Chem"},{"key":"636_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.expneurol.2014.05.008","volume":"268","author":"Y Cheng","year":"2015","unstructured":"Cheng Y, Bernstein A, Chen D, Jin P. 5-Hydroxymethylcytosine: a new player in brain disorders? Exp Neurol. 2015;268:3\u20139.","journal-title":"Exp Neurol"},{"key":"636_CR10","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.stemcr.2018.02.014","volume":"10","author":"S Chrysanthou","year":"2018","unstructured":"Chrysanthou S, Senner CE, Woods L, Fineberg E, Okkenhaug H, Burge S, et al. A critical role of TET1\/2 proteins in cell-cycle progression of trophoblast stem cells. Stem Cell Reports. 2018;10:1355\u201368.","journal-title":"Stem Cell Reports"},{"key":"636_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.cell.2011.06.020","volume":"146","author":"S Cortellino","year":"2011","unstructured":"Cortellino S, Xu J, Sannai M, Moore R, Caretti E, Cigliano A, et al. Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair. Cell. 2011;146:67\u201379.","journal-title":"Cell"},{"key":"636_CR12","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1056\/NEJMoa1716984","volume":"378","author":"CD DiNardo","year":"2018","unstructured":"DiNardo CD, Stein EM, de Botton S, Roboz GJ, Altman JK, Mims AS, et al. Durable remissions with ivosidenib in IDH1-mutated relapsed or refractory AML. N Engl J Med. 2018;378:2386\u201398.","journal-title":"N Engl J Med"},{"key":"636_CR13","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.2217\/epi.15.39","volume":"7","author":"Q Du","year":"2015","unstructured":"Du Q, Luu PL, Stirzaker C, Clark SJ. Methyl-CpG-binding domain proteins: readers of the epigenome. Epigenomics. 2015;7:1051\u201373.","journal-title":"Epigenomics"},{"key":"636_CR14","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3389\/fonc.2019.00210","volume":"9","author":"Y Feng","year":"2019","unstructured":"Feng Y, Li X, Cassady K, Zou Z, Zhang X. TET2 function in hematopoietic malignancies, immune regulation, and DNA repair. Front Oncol. 2019;9:210.","journal-title":"Front Oncol"},{"key":"636_CR15","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/nature10008","volume":"473","author":"G Ficz","year":"2011","unstructured":"Ficz G, Branco MR, Seisenberger S, Santos F, Krueger F, Hore TA, et al. Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature. 2011;473:398\u2013402.","journal-title":"Nature"},{"key":"636_CR16","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1126\/science.abb4542","volume":"372","author":"K Fugger","year":"2021","unstructured":"Fugger K, Bajrami I, Silva Dos Santos M, Young SJ, Kunzelmann S, Kelly G, et al. Targeting the nucleotide salvage factor DNPH1 sensitizes BRCA-deficient cells to PARP inhibitors. Science. 2021;372:156\u201365.","journal-title":"Science"},{"key":"636_CR17","doi-asserted-by":"publisher","first-page":"6230","DOI":"10.1038\/s41467-022-33742-7","volume":"13","author":"RO Georges","year":"2022","unstructured":"Georges RO, Sepulveda H, Angel JC, Johnson E, Palomino S, Nowak RB, et al. Acute deletion of TET enzymes results in aneuploidy in mouse embryonic stem cells through decreased expression of Khdc3. Nat Commun. 2022;13:6230.","journal-title":"Nat Commun"},{"key":"636_CR18","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s00401-018-1821-3","volume":"135","author":"WK Glowacka","year":"2018","unstructured":"Glowacka WK, Jain H, Okura M, Maimaitiming A, Mamatjan Y, Nejad R, et al. 5-Hydroxymethylcytosine preferentially targets genes upregulated in isocitrate dehydrogenase 1 mutant high-grade glioma. Acta Neuropathol. 2018;135:617\u201334.","journal-title":"Acta Neuropathol"},{"key":"636_CR19","doi-asserted-by":"publisher","first-page":"315","DOI":"10.18632\/oncotarget.13324","volume":"8","author":"F Gong","year":"2017","unstructured":"Gong F, Guo Y, Niu Y, Jin J, Zhang X, Shi X, et al. Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma. Oncotarget. 2017;8:315\u201328.","journal-title":"Oncotarget"},{"key":"636_CR20","doi-asserted-by":"crossref","unstructured":"Gulmez Karaca K, Brito DVC, Oliveira AMM. MeCP2: a critical regulator of chromatin in neurodevelopment and adult brain function. Int J Mol Sci. 2019;20.","DOI":"10.3390\/ijms20184577"},{"key":"636_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41419-022-05406-3","volume":"14","author":"XJ Guo","year":"2023","unstructured":"Guo XJ, Huang XY, Yang X, Lu JC, Wei CY, Gao C, et al. Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC\/PCAF\/AKT axis. Cell Death Dis. 2023;14:79.","journal-title":"Cell Death Dis"},{"key":"636_CR22","doi-asserted-by":"publisher","first-page":"627","DOI":"10.18632\/oncotarget.316","volume":"2","author":"MC Haffner","year":"2011","unstructured":"Haffner MC, Chaux A, Meeker AK, Esopi DM, Gerber J, Pellakuru LG, et al. Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem\/progenitor cell compartments and in human cancers. Oncotarget. 2011;2:627\u201337.","journal-title":"Oncotarget"},{"key":"636_CR23","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.4161\/cc.25010","volume":"12","author":"MC Haffner","year":"2013","unstructured":"Haffner MC, Pellakuru LG, Ghosh S, Lotan TL, Nelson WG, De Marzo AM, et al. Tight correlation of 5-hydroxymethylcytosine and Polycomb marks in health and disease. Cell Cycle. 2013;12:1835\u201341.","journal-title":"Cell Cycle"},{"key":"636_CR24","first-page":"141","volume":"75","author":"C Hage Chehade","year":"2025","unstructured":"Hage Chehade C, Gebrael G, Sayegh N, Ozay ZI, Narang A, Crispino T, et al. A pan-tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors. CA Cancer J Clin. 2025;75:141\u201367.","journal-title":"CA Cancer J Clin"},{"key":"636_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1009646","volume":"17","author":"Y Hagihara","year":"2021","unstructured":"Hagihara Y, Asada S, Maeda T, Nakano T, Yamaguchi S. Tet1 regulates epigenetic remodeling of the pericentromeric heterochromatin and chromocenter organization in DNA hypomethylated cells. PLoS Genet. 2021;17:e1009646.","journal-title":"PLoS Genet"},{"key":"636_CR26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2512204122","volume":"122","author":"JS Hardwick","year":"2025","unstructured":"Hardwick JS, Dhir S, Kirchner A, Simeone A, Flynn SM, Edgerton JM, et al. SCoTCH-seq reveals that 5-hydroxymethylcytosine encodes regulatory information across DNA strands. Proc Natl Acad Sci USA. 2025;122:e2512204122.","journal-title":"Proc Natl Acad Sci USA"},{"key":"636_CR27","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1038\/s41467-021-24425-w","volume":"12","author":"B He","year":"2021","unstructured":"He B, Zhang C, Zhang X, Fan Y, Zeng H, Liu J, et al. Tissue-specific 5-hydroxymethylcytosine landscape of the human genome. Nat Commun. 2021;12:4249.","journal-title":"Nat Commun"},{"key":"636_CR28","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1126\/science.1210944","volume":"333","author":"YF He","year":"2011","unstructured":"He YF, Li BZ, Li Z, Liu P, Wang Y, Tang Q, et al. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science. 2011;333:1303\u20137.","journal-title":"Science"},{"key":"636_CR29","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.tig.2014.07.005","volume":"30","author":"Y Huang","year":"2014","unstructured":"Huang Y, Rao A. Connections between TET proteins and aberrant DNA modification in cancer. Trends Genet. 2014;30:464\u201374.","journal-title":"Trends Genet"},{"key":"636_CR30","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/nature09303","volume":"466","author":"S Ito","year":"2010","unstructured":"Ito S, D\u2019Alessio AC, Taranova OV, Hong K, Sowers LC, Zhang Y. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature. 2010;466:1129\u201333.","journal-title":"Nature"},{"key":"636_CR31","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1126\/science.1210597","volume":"333","author":"S Ito","year":"2011","unstructured":"Ito S, Shen L, Dai Q, Wu SC, Collins LB, Swenberg JA, et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science. 2011;333:1300\u20133.","journal-title":"Science"},{"key":"636_CR32","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1146\/annurev-cancerbio-070820-035832","volume":"5","author":"LT Izzo","year":"2021","unstructured":"Izzo LT, Affronti HC, Wellen KE. The bidirectional relationship between cancer epigenetics and metabolism. Annu Rev Cancer Biol. 2021;5:235\u201357.","journal-title":"Annu Rev Cancer Biol"},{"key":"636_CR33","doi-asserted-by":"publisher","first-page":"781","DOI":"10.15252\/embr.201643179","volume":"18","author":"D Jiang","year":"2017","unstructured":"Jiang D, Wei S, Chen F, Zhang Y, Li J. TET3-mediated DNA oxidation promotes ATR-dependent DNA damage response. EMBO Rep. 2017;18:781\u201396.","journal-title":"EMBO Rep"},{"key":"636_CR34","doi-asserted-by":"publisher","first-page":"13177","DOI":"10.1038\/ncomms13177","volume":"7","author":"KC Johnson","year":"2016","unstructured":"Johnson KC, Houseman EA, King JE, von Herrmann KM, Fadul CE, Christensen BC. 5-Hydroxymethylcytosine localizes to enhancer elements and is associated with survival in glioblastoma patients. Nat Commun. 2016;7:13177.","journal-title":"Nat Commun"},{"key":"636_CR35","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.celrep.2016.01.035","volume":"14","author":"GR Kafer","year":"2016","unstructured":"Kafer GR, Li X, Horii T, Suetake I, Tajima S, Hatada I, et al. 5-Hydroxymethylcytosine marks sites of DNA damage and promotes genome stability. Cell Rep. 2016;14:1283\u201392.","journal-title":"Cell Rep"},{"key":"636_CR36","doi-asserted-by":"crossref","unstructured":"Kharat SS, Ding X, Swaminathan D, Suresh A, Singh M, Sengodan SK, Burkett S, Marks H, Pamala C, He Y, Fox SD, Buehler EC, Muegge K, Martin SE, Sharan SK. Degradation of 5hmC-marked stalled replication forks by APE1 causes genomic instability. Sci Signal. 2020;13.","DOI":"10.1126\/scisignal.aba8091"},{"key":"636_CR37","doi-asserted-by":"crossref","unstructured":"Kharat SS, Mishra AP, Sengodan SK, Dierman D, Fox SD, Chazin WJ, Sharan SK. 5hmC enhances PARP trapping and restores PARP inhibitor sensitivity in chemoresistant BRCA1\/2-deficient cells. J Biol Chem. 2025;110393.","DOI":"10.1101\/2024.10.25.620335"},{"key":"636_CR38","doi-asserted-by":"publisher","first-page":"1827904","DOI":"10.1080\/23723556.2020.1827904","volume":"7","author":"SS Kharat","year":"2020","unstructured":"Kharat SS, Sharan SK. Exploring role of 5hmC as potential marker of chemoresistance. Mol Cell Oncol. 2020;7:1827904.","journal-title":"Mol Cell Oncol"},{"key":"636_CR39","doi-asserted-by":"publisher","DOI":"10.1017\/pcm.2024.2","volume":"2","author":"MAS Khoodoruth","year":"2024","unstructured":"Khoodoruth MAS, Chut-Kai Khoodoruth WN, Al Alwani R. Exploring the epigenetic landscape: the role of 5-hydroxymethylcytosine in neurodevelopmental disorders. Camb Prism Precis Med. 2024;2:e5.","journal-title":"Camb Prism Precis Med"},{"key":"636_CR40","doi-asserted-by":"publisher","first-page":"14566","DOI":"10.1073\/pnas.1112317108","volume":"108","author":"M Ko","year":"2011","unstructured":"Ko M, Bandukwala HS, An J, Lamperti ED, Thompson EC, Hastie R, et al. Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice. Proc Natl Acad Sci USA. 2011;108:14566\u201371.","journal-title":"Proc Natl Acad Sci USA"},{"key":"636_CR41","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1126\/science.1169786","volume":"324","author":"S Kriaucionis","year":"2009","unstructured":"Kriaucionis S, Heintz N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science. 2009;324:929\u201330.","journal-title":"Science"},{"key":"636_CR42","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12957-025-03747-9","volume":"23","author":"S Kuerban","year":"2025","unstructured":"Kuerban S, Chen H, Chen L, Zhang L, Li X, Zhen B, et al. cfDNA hydroxymethylcytosine profiling for detection metastasis and recurrence of Esophageal Squamous Cell Carcinoma. World J Surg Oncol. 2025;23:90.","journal-title":"World J Surg Oncol"},{"key":"636_CR43","doi-asserted-by":"publisher","first-page":"86395","DOI":"10.18632\/oncotarget.21189","volume":"8","author":"BT Li","year":"2017","unstructured":"Li BT, Yu C, Xu Y, Liu SB, Fan HY, Pan WW. TET1 inhibits cell proliferation by inducing RASSF5 expression. Oncotarget. 2017;8:86395\u2013409.","journal-title":"Oncotarget"},{"key":"636_CR44","doi-asserted-by":"publisher","first-page":"26591","DOI":"10.1038\/srep26591","volume":"6","author":"L Li","year":"2016","unstructured":"Li L, Li C, Mao H, Du Z, Chan WY, Murray P, et al. Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers. Sci Rep. 2016;6:26591.","journal-title":"Sci Rep"},{"key":"636_CR45","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s43856-025-00783-0","volume":"5","author":"Q Li","year":"2025","unstructured":"Li Q, Huang CC, Huang S, Tian Y, Huang J, Bitaraf A, et al. 5-hydroxymethylcytosine sequencing of plasma cell-free DNA identifies epigenomic features in prostate cancer patients receiving androgen deprivation therapies. Commun Med (Lond). 2025;5:61.","journal-title":"Commun Med (Lond)"},{"key":"636_CR46","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.cell.2012.07.033","volume":"150","author":"CG Lian","year":"2012","unstructured":"Lian CG, Xu Y, Ceol C, Wu F, Larson A, Dresser K, et al. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell. 2012;150:1135\u201346.","journal-title":"Cell"},{"key":"636_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202300445","volume":"10","author":"G Liang","year":"2023","unstructured":"Liang G, Wang L, You Q, Cahill K, Chen C, Zhang W, et al. Cellular composition and 5hmC signature predict the treatment response of AML patients to azacitidine combined with chemotherapy. Adv Sci (Weinh). 2023;10:e2300445.","journal-title":"Adv Sci (Weinh)"},{"key":"636_CR48","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.3892\/ol.2016.4474","volume":"11","author":"Y Liao","year":"2016","unstructured":"Liao Y, Gu J, Wu Y, Long X, Ge DI, Xu J, et al. Low level of 5-Hydroxymethylcytosine predicts poor prognosis in non-small cell lung cancer. Oncol Lett. 2016;11:3753\u201360.","journal-title":"Oncol Lett"},{"issue":"233\u2013247","key":"636_CR49","volume":"167","author":"XS Liu","year":"2016","unstructured":"Liu XS, Wu H, Ji X, Stelzer Y, Wu X, Czauderna S, et al. Editing DNA Methylation in the Mammalian Genome. Cell. 2016;167(233\u2013247):e217.","journal-title":"Cell"},{"key":"636_CR50","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1126\/science.aam7344","volume":"355","author":"CJ Lord","year":"2017","unstructured":"Lord CJ, Ashworth A. PARP inhibitors: synthetic lethality in the clinic. Science. 2017;355:1152\u20138.","journal-title":"Science"},{"key":"636_CR51","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/s41419-023-06329-3","volume":"14","author":"D Lu","year":"2023","unstructured":"Lu D, Wu X, Wu W, Wu S, Li H, Zhang Y, et al. Plasma cell-free DNA 5-hydroxymethylcytosine and whole-genome sequencing signatures for early detection of esophageal cancer. Cell Death Dis. 2023;14:843.","journal-title":"Cell Death Dis"},{"key":"636_CR52","doi-asserted-by":"publisher","first-page":"76047","DOI":"10.18632\/oncotarget.12583","volume":"7","author":"H Lu","year":"2016","unstructured":"Lu H, Bhoopatiraju S, Wang H, Schmitz NP, Wang X, Freeman MJ, et al. Loss of UHRF2 expression is associated with human neoplasia, promoter hypermethylation, decreased 5-hydroxymethylcytosine, and high proliferative activity. Oncotarget. 2016;7:76047\u201361.","journal-title":"Oncotarget"},{"issue":"47\u201352","key":"636_CR53","volume":"98","author":"KJ MacBeth","year":"2021","unstructured":"MacBeth KJ, Chopra VS, Tang L, Zheng B, Avanzino B, See WL, et al. Combination of azacitidine and enasidenib enhances leukemic cell differentiation and cooperatively hypomethylates DNA. Exp Hematol. 2021;98(47\u201352):e46.","journal-title":"Exp Hematol"},{"key":"636_CR54","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.dnarep.2016.05.031","volume":"43","author":"E Mahfoudhi","year":"2016","unstructured":"Mahfoudhi E, Talhaoui I, Cabagnols X, Della Valle V, Secardin L, Rameau P, et al. TET2-mediated 5-hydroxymethylcytosine induces genetic instability and mutagenesis. DNA Repair (Amst). 2016;43:78\u201388.","journal-title":"DNA Repair (Amst)"},{"key":"636_CR55","doi-asserted-by":"publisher","first-page":"35334","DOI":"10.1074\/jbc.C111.284620","volume":"286","author":"A Maiti","year":"2011","unstructured":"Maiti A, Drohat AC. Thymine DNA glycosylase can rapidly excise 5-formylcytosine and 5-carboxylcytosine: potential implications for active demethylation of CpG sites. J Biol Chem. 2011;286:35334\u20138.","journal-title":"J Biol Chem"},{"key":"636_CR56","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/bjh.13566","volume":"171","author":"E Marchi","year":"2015","unstructured":"Marchi E, Zullo KM, Amengual JE, Kalac M, Bongero D, McIntosh CM, et al. The combination of hypomethylating agents and histone deacetylase inhibitors produce marked synergy in preclinical models of T-cell lymphoma. Br J Haematol. 2015;171:215\u201326.","journal-title":"Br J Haematol"},{"key":"636_CR57","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.cell.2012.11.022","volume":"151","author":"M Mellen","year":"2012","unstructured":"Mellen M, Ayata P, Dewell S, Kriaucionis S, Heintz N. MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell. 2012;151:1417\u201330.","journal-title":"Cell"},{"key":"636_CR58","doi-asserted-by":"publisher","first-page":"5588","DOI":"10.1158\/0008-5472.CAN-12-2753","volume":"72","author":"J Murai","year":"2012","unstructured":"Murai J, Huang SY, Das BB, Renaud A, Zhang Y, Doroshow JH, et al. Trapping of PARP1 and PARP2 by clinical PARP inhibitors. Cancer Res. 2012;72:5588\u201399.","journal-title":"Cancer Res"},{"key":"636_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041036","volume":"7","author":"BA Orr","year":"2012","unstructured":"Orr BA, Haffner MC, Nelson WG, Yegnasubramanian S, Eberhart CG. Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma. PLoS ONE. 2012;7:e41036.","journal-title":"PLoS ONE"},{"key":"636_CR60","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10238-024-01297-0","volume":"24","author":"X Pan","year":"2024","unstructured":"Pan X, Chang Y, Ruan G, Zhou S, Jiang H, Jiang Q, et al. TET2 mutations contribute to adverse prognosis in acute myeloid leukemia (AML): results from a comprehensive analysis of 502 AML cases and the Beat AML public database. Clin Exp Med. 2024;24:35.","journal-title":"Clin Exp Med"},{"key":"636_CR61","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1101\/gr.213983.116","volume":"27","author":"C Papin","year":"2017","unstructured":"Papin C, Ibrahim A, Gras SL, Velt A, Stoll I, Jost B, et al. Combinatorial DNA methylation codes at repetitive elements. Genome Res. 2017;27:934\u201346.","journal-title":"Genome Res"},{"key":"636_CR62","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/nature10102","volume":"473","author":"WA Pastor","year":"2011","unstructured":"Pastor WA, Pape UJ, Huang Y, Henderson HR, Lister R, Ko M, et al. Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells. Nature. 2011;473:394\u20137.","journal-title":"Nature"},{"key":"636_CR63","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13148-018-0527-7","volume":"10","author":"D Peng","year":"2018","unstructured":"Peng D, Ge G, Gong Y, Zhan Y, He S, Guan B, et al. Vitamin C increases 5-hydroxymethylcytosine level and inhibits the growth of bladder cancer. Clin Epigenetics. 2018;10:94.","journal-title":"Clin Epigenetics"},{"key":"636_CR64","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1756-8935-6-10","volume":"6","author":"GP Pfeifer","year":"2013","unstructured":"Pfeifer GP, Kadam S, Jin SG. 5-hydroxymethylcytosine and its potential roles in development and cancer. Epigenetics Chromatin. 2013;6:10.","journal-title":"Epigenetics Chromatin"},{"key":"636_CR65","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00441-014-1896-7","volume":"356","author":"GP Pfeifer","year":"2014","unstructured":"Pfeifer GP, Xiong W, Hahn MA, Jin SG. The role of 5-hydroxymethylcytosine in human cancer. Cell Tissue Res. 2014;356:631\u201341.","journal-title":"Cell Tissue Res"},{"key":"636_CR66","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1111\/cup.12564","volume":"42","author":"N Rodic","year":"2015","unstructured":"Rodic N, Zampella J, Sharma R, Burns KH, Taube JM. Diagnostic utility of 5-hydroxymethylcytosine immunohistochemistry in melanocytic proliferations. J Cutan Pathol. 2015;42:807\u201314.","journal-title":"J Cutan Pathol"},{"key":"636_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.564601","volume":"8","author":"M Rose","year":"2020","unstructured":"Rose M, Burgess JT, O\u2019Byrne K, Richard DJ, Bolderson E. PARP inhibitors: clinical relevance, mechanisms of action and tumor resistance. Front Cell Dev Biol. 2020;8:564601.","journal-title":"Front Cell Dev Biol"},{"key":"636_CR68","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.neuron.2013.08.003","volume":"79","author":"A Rudenko","year":"2013","unstructured":"Rudenko A, Dawlaty MM, Seo J, Cheng AW, Meng J, Le T, et al. Tet1 is critical for neuronal activity-regulated gene expression and memory extinction. Neuron. 2013;79:1109\u201322.","journal-title":"Neuron"},{"key":"636_CR69","doi-asserted-by":"publisher","first-page":"5306","DOI":"10.1038\/s41598-018-23714-7","volume":"8","author":"DW Sant","year":"2018","unstructured":"Sant DW, Mustafi S, Gustafson CB, Chen J, Slingerland JM, Wang G. Vitamin C promotes apoptosis in breast cancer cells by increasing TRAIL expression. Sci Rep. 2018;8:5306.","journal-title":"Sci Rep"},{"key":"636_CR70","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz001","volume":"47","author":"CE Schlosberg","year":"2019","unstructured":"Schlosberg CE, Wu DY, Gabel HW, Edwards JR. ME-Class2 reveals context dependent regulatory roles for 5-hydroxymethylcytosine. Nucleic Acids Res. 2019;47:e28.","journal-title":"Nucleic Acids Res"},{"key":"636_CR71","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.stemcr.2020.04.009","volume":"15","author":"CE Senner","year":"2020","unstructured":"Senner CE, Chrysanthou S, Burge S, Lin HY, Branco MR, Hemberger M. TET1 and 5-hydroxymethylation preserve the stem cell state of mouse trophoblast. Stem Cell Reports. 2020;15:1301\u201316.","journal-title":"Stem Cell Reports"},{"key":"636_CR72","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.cell.2013.04.002","volume":"153","author":"L Shen","year":"2013","unstructured":"Shen L, Wu H, Diep D, Yamaguchi S, D\u2019Alessio AC, Fung HL, et al. Genome-wide analysis reveals TET- and TDG-dependent 5-methylcytosine oxidation dynamics. Cell. 2013;153:692\u2013706.","journal-title":"Cell"},{"key":"636_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2017.65","volume":"7","author":"N Shenoy","year":"2017","unstructured":"Shenoy N, Bhagat T, Nieves E, Stenson M, Lawson J, Choudhary GS, et al. Upregulation of TET activity with ascorbic acid induces epigenetic modulation of lymphoma cells. Blood Cancer J. 2017;7:e587.","journal-title":"Blood Cancer J"},{"key":"636_CR74","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nmeth.1779","volume":"9","author":"CX Song","year":"2011","unstructured":"Song CX, Clark TA, Lu XY, Kislyuk A, Dai Q, Turner SW, et al. Sensitive and specific single-molecule sequencing of 5-hydroxymethylcytosine. Nat Methods. 2011;9:75\u20137.","journal-title":"Nat Methods"},{"key":"636_CR75","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ygeno.2014.08.021","volume":"104","author":"W Sun","year":"2014","unstructured":"Sun W, Zang L, Shu Q, Li X. From development to diseases: the role of 5hmC in brain. Genomics. 2014;104:347\u201351.","journal-title":"Genomics"},{"key":"636_CR76","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3389\/fonc.2018.00092","volume":"8","author":"A Suraweera","year":"2018","unstructured":"Suraweera A, O\u2019Byrne KJ, Richard DJ. Combination therapy with histone deacetylase inhibitors (HDACi) for the treatment of cancer: achieving the full therapeutic potential of HDACi. Front Oncol. 2018;8:92.","journal-title":"Front Oncol"},{"key":"636_CR77","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1126\/science.1170116","volume":"324","author":"M Tahiliani","year":"2009","unstructured":"Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science. 2009;324:930\u20135.","journal-title":"Science"},{"key":"636_CR78","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nature19081","volume":"537","author":"B Thienpont","year":"2016","unstructured":"Thienpont B, Steinbacher J, Zhao H, D\u2019Anna F, Kuchnio A, Ploumakis A, et al. Tumour hypoxia causes DNA hypermethylation by reducing TET activity. Nature. 2016;537:63\u20138.","journal-title":"Nature"},{"key":"636_CR79","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1158\/1078-0432.CCR-17-1958","volume":"24","author":"DW Tucker","year":"2018","unstructured":"Tucker DW, Getchell CR, McCarthy ET, Ohman AW, Sasamoto N, Xu S, et al. Epigenetic reprogramming strategies to reverse global loss of 5-hydroxymethylcytosine, a prognostic factor for poor survival in high-grade serous ovarian cancer. Clin Cancer Res. 2018;24:1389\u2013401.","journal-title":"Clin Cancer Res"},{"key":"636_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114815","volume":"43","author":"P Wang","year":"2024","unstructured":"Wang P, Chen LL, Xiong Y, Ye D. Metabolite regulation of epigenetics in cancer. Cell Rep. 2024;43:114815.","journal-title":"Cell Rep"},{"key":"636_CR81","doi-asserted-by":"crossref","unstructured":"Wang X, Sarver AL, Han Q, Seiler CL, Xie C, Lu H, Forster CL, Tretyakova NY, Hallstrom TC. UHRF2 regulates cell cycle, epigenetics and gene expression to control the timing of retinal progenitor and ganglion cell differentiation. Development. 2022;149.","DOI":"10.1242\/dev.195644"},{"key":"636_CR82","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13072-018-0252-7","volume":"12","author":"S Wernig-Zorc","year":"2019","unstructured":"Wernig-Zorc S, Yadav MP, Kopparapu PK, Bemark M, Kristjansdottir HL, Andersson PO, et al. Global distribution of DNA hydroxymethylation and DNA methylation in chronic lymphocytic leukemia. Epigenetics Chromatin. 2019;12:4.","journal-title":"Epigenetics Chromatin"},{"key":"636_CR83","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1101\/gad.179184.111","volume":"25","author":"H Wu","year":"2011","unstructured":"Wu H, Zhang Y. Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation. Genes Dev. 2011;25:2436\u201352.","journal-title":"Genes Dev"},{"key":"636_CR84","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/1701072a0","volume":"170","author":"GR Wyatt","year":"1952","unstructured":"Wyatt GR, Cohen SS. A new pyrimidine base from bacteriophage nucleic acids. Nature. 1952;170:1072\u20133.","journal-title":"Nature"},{"key":"636_CR85","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","volume":"19","author":"W Xu","year":"2011","unstructured":"Xu W, Yang H, Liu Y, Yang Y, Wang P, Kim SH, et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases. Cancer Cell. 2011;19:17\u201330.","journal-title":"Cancer Cell"},{"key":"636_CR86","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature11709","volume":"492","author":"S Yamaguchi","year":"2012","unstructured":"Yamaguchi S, Hong K, Liu R, Shen L, Inoue A, Diep D, et al. Tet1 controls meiosis by regulating meiotic gene expression. Nature. 2012;492:443\u20137.","journal-title":"Nature"},{"key":"636_CR87","doi-asserted-by":"publisher","first-page":"5562","DOI":"10.1158\/1078-0432.CCR-12-1773","volume":"18","author":"H Yang","year":"2012","unstructured":"Yang H, Ye D, Guan KL, Xiong Y. IDH1 and IDH2 mutations in tumorigenesis: mechanistic insights and clinical perspectives. Clin Cancer Res. 2012;18:5562\u201371.","journal-title":"Clin Cancer Res"},{"key":"636_CR88","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.cell.2011.11.054","volume":"147","author":"O Yildirim","year":"2011","unstructured":"Yildirim O, Li R, Hung JH, Chen PB, Dong X, Ee LS, et al. Mbd3\/NURD complex regulates expression of 5-hydroxymethylcytosine marked genes in embryonic stem cells. Cell. 2011;147:1498\u2013510.","journal-title":"Cell"},{"key":"636_CR89","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1093\/nar\/28.10.2201","volume":"28","author":"F Yu","year":"2000","unstructured":"Yu F, Thiesen J, Stratling WH. Histone deacetylase-independent transcriptional repression by methyl-CpG-binding protein 2. Nucleic Acids Res. 2000;28:2201\u20136.","journal-title":"Nucleic Acids Res"},{"key":"636_CR90","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.molcel.2014.04.003","volume":"54","author":"T Zhou","year":"2014","unstructured":"Zhou T, Xiong J, Wang M, Yang N, Wong J, Zhu B, et al. Structural basis for hydroxymethylcytosine recognition by the SRA domain of UHRF2. Mol Cell. 2014;54:879\u201386.","journal-title":"Mol Cell"}],"container-title":["Epigenetics &amp; Chromatin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13072-025-00636-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13072-025-00636-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13072-025-00636-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T22:06:52Z","timestamp":1763417212000},"score":1,"resource":{"primary":{"URL":"https:\/\/epigeneticsandchromatin.biomedcentral.com\/articles\/10.1186\/s13072-025-00636-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["636"],"URL":"https:\/\/doi.org\/10.1186\/s13072-025-00636-z","relation":{},"ISSN":["1756-8935"],"issn-type":[{"value":"1756-8935","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"27 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"73"}}